11012469

Source:http://linkedlifedata.com/resource/pubmed/id/11012469

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017431, umls-concept:C0050940, umls-concept:C0378482, umls-concept:C0442113, umls-concept:C0449438, umls-concept:C1332828
pubmed:issue	10
pubmed:dateCreated	2000-11-16
pubmed:abstractText	CYP2C19 has an important role in the catabolism of several proton pump inhibitors. However, the relative contribution of CYP2C19-mediated metabolism varies among the different proton pump inhibitors.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents, http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases, http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/CYP2C19 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Mixed Function Oxygenases, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Proton Pumps, http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole, http://linkedlifedata.com/resource/pubmed/chemical/rabeprazole
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0269-2813
pubmed:author	pubmed-author:AdachiKK, pubmed-author:AmanoKK, pubmed-author:FukudaRR, pubmed-author:IshiharaSS, pubmed-author:KatsubeTT, pubmed-author:KawamuraAA, pubmed-author:KinoshitaYY, pubmed-author:TakashimaTT, pubmed-author:WatanabeMM, pubmed-author:YukiMM
pubmed:issnType	Print
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1259-66
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11012469-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:11012469-Adult, pubmed-meshheading:11012469-Anti-Ulcer Agents, pubmed-meshheading:11012469-Aryl Hydrocarbon Hydroxylases, pubmed-meshheading:11012469-Benzimidazoles, pubmed-meshheading:11012469-Cytochrome P-450 Enzyme System, pubmed-meshheading:11012469-Enzyme Inhibitors, pubmed-meshheading:11012469-Gastric Acid, pubmed-meshheading:11012469-Gastric Acidity Determination, pubmed-meshheading:11012469-Genotype, pubmed-meshheading:11012469-Humans, pubmed-meshheading:11012469-Hydrogen-Ion Concentration, pubmed-meshheading:11012469-Male, pubmed-meshheading:11012469-Middle Aged, pubmed-meshheading:11012469-Mixed Function Oxygenases, pubmed-meshheading:11012469-Omeprazole, pubmed-meshheading:11012469-Polymorphism, Restriction Fragment Length, pubmed-meshheading:11012469-Proton Pumps
pubmed:year	2000
pubmed:articleTitle	CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole.
pubmed:affiliation	Department of Internal Medicine II, Shimane Medical University, Izumo, Shimane, Japan. kadachi@shimane-med.ac.jp
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't